Zura Bio Limited

Zura Bio Limited

Biotechnology, 6154 Nancy RDG Dr, Henderson, Nevada, 92121, United States, 11-50 Employees

zurabio.com

  • LinkedIn

phone no Phone Number: +12*********

Who is ZURA BIO LIMITED

Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets ...

Read More

map
  • 6154 Nancy RDG Dr, Henderson, Nevada, 92121, United States Headquarters: 6154 Nancy RDG Dr, Henderson, Nevada, 92121, United States
  • 2022 Date Founded: 2022
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $250 Million to $500 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 325414 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ZURA BIO LIMITED

Zura Bio Limited Org Chart and Mapping

Employees

Janette Lo

Senior Manager, Finance

Kim Davis

EVP, General Counsel and Corporate Secretary

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Zura Bio Limited

Answer: Zura Bio Limited's headquarters are located at 6154 Nancy RDG Dr, Henderson, Nevada, 92121, United States

Answer: Zura Bio Limited's phone number is +12*********

Answer: Zura Bio Limited's official website is https://zurabio.com

Answer: Zura Bio Limited's revenue is $250 Million to $500 Million

Answer: Zura Bio Limited's SIC: 2836

Answer: Zura Bio Limited's NAICS: 325414

Answer: Zura Bio Limited has 11-50 employees

Answer: Zura Bio Limited is in Biotechnology

Answer: Zura Bio Limited contact info: Phone number: +12********* Website: https://zurabio.com

Answer: Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets which have completed phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), torudokimab (ZB-880), and ZB-168 with a goal of demonstrating their efficacy, safety, and dosing convenience in immune and inflammatory disorders. Zura Bio is headquartered in Henderson, NV with team members in the UK and USA.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access